Literature DB >> 9379012

Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase.

L H Mason1, P Gosselin, S K Anderson, W E Fogler, J R Ortaldo, D W McVicar.   

Abstract

Killer cell inhibitory receptors represent a family of p58/70-Ig-like proteins expressed on the surface of human NK cells. Engagement of class I MHC by killer cell inhibitory receptors turns off the lytic machinery of NK cells. This receptor/ligand interaction results in phosphorylation of intracellular tyrosine residues of p58/70 proteins. Murine NK cells express surface receptors of an unrelated family of type II lectin-like proteins, Ly-49, that have similar functions. Ly-49A, -C, and -G2 represent murine inhibitory receptors. However, Ly-49D functions as an activation receptor on the surface of NK cells. This dichotomy of function between Ly-49 family members suggested different signaling events upon receptor/ligand interaction. Here we demonstrate that: 1) in transfected Cos7 and murine NK cells, Ly-49A, -C, and -G2 are phosphorylated following pervanadate stimulation, whereas Ly-49D is not; 2) mAb-induced receptor ligation mediates tyrosine phosphorylation of Ly-49A and -G2, but not Ly-49D; 3) SHP-1 coprecipitates with Ly-49A and -G2 following receptor phosphorylation; and 4) tyrosine phosphorylation of Ly-49 inhibitory receptors depends on tyrosine residues restricted to the immunoreceptor tyrosine-based inhibitory motif. Our data further support the involvement of immunoreceptor tyrosine-based inhibitory motifs as crucial sequences regulating receptor-mediated inhibitory functions in NK cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9379012

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Regulation of ITAM-positive receptors: role of IL-12 and IL-18.

Authors:  John R Ortaldo; Robin Winkler-Pickett; Jon Wigginton; Meagan Horner; Earl W Bere; Anna T Mason; Narayan Bhat; James Cherry; Michael Sanford; Deborah L Hodge; Howard A Young
Journal:  Blood       Date:  2005-10-25       Impact factor: 22.113

Review 2.  The balancing act: inhibitory Ly49 regulate NKG2D-mediated NK cell functions.

Authors:  Subramaniam Malarkannan
Journal:  Semin Immunol       Date:  2006-06       Impact factor: 11.130

Review 3.  Ly49 gene expression in different inbred mouse strains.

Authors:  A P Makrigiannis; S K Anderson
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

4.  NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors.

Authors:  Jeyarani Regunathan; Yuhong Chen; Demin Wang; Subramaniam Malarkannan
Journal:  Blood       Date:  2004-08-24       Impact factor: 22.113

5.  Genomic organization and evolutionary analysis of Ly49 genes encoding the rodent natural killer cell receptors: rapid evolution by repeated gene duplication.

Authors:  Li Hao; Masatoshi Nei
Journal:  Immunogenetics       Date:  2004-08-14       Impact factor: 2.846

6.  Targeted delivery of murine IFN-gamma using a recombinant fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunity.

Authors:  Hasan Zeytin; Eva Reali; David A Zaharoff; Connie J Rogers; Jeffrey Schlom; John W Greiner
Journal:  J Interferon Cytokine Res       Date:  2008-02       Impact factor: 2.607

7.  Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome.

Authors:  S Belanger; L-H Tai; S K Anderson; A P Makrigiannis
Journal:  Genes Immun       Date:  2008-06-05       Impact factor: 2.676

8.  Ligand dimensions are important in controlling NK-cell responses.

Authors:  Joanna Brzostek; Jian-Guo Chai; Friedemann Gebhardt; Dirk H Busch; Rui Zhao; P Anton van der Merwe; Keith G Gould
Journal:  Eur J Immunol       Date:  2010-07       Impact factor: 5.532

Review 9.  Ly49 receptors: innate and adaptive immune paradigms.

Authors:  Mir Munir A Rahim; Megan M Tu; Ahmad Bakur Mahmoud; Andrew Wight; Elias Abou-Samra; Patricia D A Lima; Andrew P Makrigiannis
Journal:  Front Immunol       Date:  2014-04-02       Impact factor: 7.561

10.  Genetic control of natural killing and in vivo tumor elimination by the Chok locus.

Authors:  A H Idris; K Iizuka; H R Smith; A A Scalzo; W M Yokoyama
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.